Abstract
Contemporary treatment of brain diseases has been hampered by limited drug delivery across the blood-brain barrier (BBB). Herein, gelatin-siloxane nanoparticles (GSNPs) with controlled size and surface charge were synthesized through a two-step sol-gel process. In order to increase the efficiency of brain targeting, HIV-derived Tat peptide and PEG were further grafted onto GS NPs (Tat-PEG-GS NPs). In vivo imaging and TEM results indicated Tat-PEG-GS NPs could not only escape the capture by reticulo-endothelial system but also cross BBB and reach central nervous system of mice. Hence, Tat-PEG-GS NPs might represent a new type of non-viral vector for the delivery of drug or therapeutic DNA to brain by crossing BBB.
Original language | English |
---|---|
Pages (from-to) | 94-96 |
Number of pages | 3 |
Journal | Materials Letters |
Volume | 68 |
DOIs | |
State | Published - 1 Feb 2012 |
Externally published | Yes |
Keywords
- Biomaterials
- Blood-brain barrier
- In vivo assay
- Nanoparticles
- Targeted delivery